% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Gaitantzi:153912,
author = {H. Gaitantzi and J. Karch and L. Germann and C. Cai and V.
Rausch and E. Birgin and N. Rahbari and T. Seitz and C.
Hellerbrand and C. König$^*$ and H. Augustin$^*$ and C.
Mogler and C. de la Torre and N. Gretz and T. Itzel and A.
Teufel and M. P. A. Ebert and K. Breitkopf-Heinlein},
title = {{BMP}-9 {M}odulates the {H}epatic {R}esponses to {LPS}.},
journal = {Cells},
volume = {9},
number = {3},
issn = {2073-4409},
address = {Basel},
publisher = {MDPI},
reportid = {DKFZ-2020-00522},
pages = {E617},
year = {2020},
note = {DKFZ-ZMBH Alliance},
abstract = {It was previously shown that Bone Morphogenetic Protein
(BMP)-9 is constitutively produced and secreted by hepatic
stellate cells (HSC). Upon acute liver damage, BMP-9
expression is transiently down-regulated and blocking BMP-9
under conditions of chronic damage ameliorated liver
fibrogenesis in C57BL/6 mice. Thereby, BMP-9 acted as a
pro-fibrogenic cytokine in the liver but without directly
activating isolated HSC in vitro. Lipopolysaccharide (LPS),
an endotoxin derived from the membrane of Gram-negative
bacteria in the gut, is known to be essential in the
pathogenesis of diverse kinds of liver diseases. The aim of
the present project was therefore to investigate how high
levels of BMP-9 in the context of LPS signalling might
result in enhanced liver damage. For this purpose, we
stimulated human liver sinusoidal endothelial cells (LSEC)
with LPS and incubated primary human liver myofibroblasts
(MF) with the conditioned medium of these cells. We found
that LPS led to the secretion of factors from LSEC that
upregulate BMP-9 expression in MF. At least one of these
BMP-9 enhancing factors was defined to be IL-6. High BMP-9
in turn, especially in combination with LPS stimulation,
induced the expression of certain capillarization markers in
LSEC and enhanced the LPS-mediated induction of
pro-inflammatory cytokines in primary human macrophages. In
LSEC, pre-treatment with BMP-9 reduced the LPS-mediated
activation of the NfkB pathway, whereas in macrophages, LPS
partially inhibited the BMP-9/Smad-1 signaling cascade. In
vivo, in mice, BMP-9 led to the enhanced presence of
F4/80-positive cells in the liver and it modulated the
LPS-mediated regulation of inflammatory mediators. In
summary, our data point to BMP-9 being a complex and highly
dynamic modulator of hepatic responses to LPS: Initial
effects of LPS on LSEC led to the upregulation of BMP-9 in
MF but sustained high levels of BMP-9 in turn promote
pro-inflammatory reactions of macrophages. Thereby, the
spatial and timely fine-tuned presence (or absence) of BMP-9
is needed for efficient wound-healing responses in the
liver.},
cin = {A190},
ddc = {570},
cid = {I:(DE-He78)A190-20160331},
pnm = {321 - Basic Concepts (POF3-321)},
pid = {G:(DE-HGF)POF3-321},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32143367},
doi = {10.3390/cells9030617},
url = {https://inrepo02.dkfz.de/record/153912},
}